Amnog Early Benefit Assessment (EBA) in Germany - A Specific Challenge for Antidiabetics

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1920
https://www.valueinhealthjournal.com/article/S1098-3015(16)33286-7/fulltext
Title : Amnog Early Benefit Assessment (EBA) in Germany - A Specific Challenge for Antidiabetics
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33286-7&doi=10.1016/j.jval.2016.09.1920
First page : A680
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1814
Categories :
Tags :
Regions :
ViH Article Tags :